#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Complex regional pain syndrome Familial hypertriglyceridaemia Chronic lymphocytic leukaemia Factor IX deficiency Hepatoblastoma Postprandial hypoglycaemia Frontotemporal dementia Vernal keratoconjunctivitis Hypereosinophilic syndrome Ureteric cancer Allogenic stem cell transplantation Pustular psoriasis Gastrointestinal disorder Sickle cell disease Asthma More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Treatment Waldenstrom’s macroglobulinaemia – Basic Information Soft tissue sarcoma – Treatment Combined immunodeficiency – Treatment Von Willebrand’s disease – Life with Disease Leiomyosarcoma – Trials in Disease KBG syndrome – Life with Disease Systemic sclerosis pulmonary – Trials in Disease Nephrotic syndrome – Basic Information Idiopathic pulmonary fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    The-630 Englumafusp Alfa Dantrolene Sodium Danicamtiv Afimetoran Besilate Dihydrate Paclitaxel Sebetralstat Lorazepam Olopatadine Alxn1850 Oxycodone Hydrochloride 18F-Fludarabine Metronidazole Pf-06480605 Medroxyprogesterone Acetate Acp-204 Tartrate Idecabtagene Vicleucel Sacituzumab Tirumotecan Methoxyflurane [18F]CPFPX More therapies…

    Learn about Your Condition

    Monkeypox Melanoma recurrent Osteomyelitis Krabbe's disease Dysmenorrhoea Bile duct cancer Dengue fever Haemorrhoids Anal cancer recurrent Epicondylitis Glycogen storage disorder Acromegaly Exposure via breast milk Electronic cigarette user Senile dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Belgium Bulgaria Denmark Finland France Germany +4

  • Study on the Effect and Safety of BW-20805 for Adults with Hereditary Angioedema

    Not recruiting

    2 1 1
    Investigated Drugs:
    • BW-20805
    Germany Italy Poland Spain

  • Study of pacritinib effectiveness and safety compared to placebo in patients with VEXAS syndrome

    Not recruiting

    2 1
    Investigated Diseases:
    • VEXAS syndrome
    Investigated Drugs:
    • Pacritinib
    France Germany Italy Spain

  • Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • HEMOPEXIN, HUMAN
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Itepekimab
    Austria Finland Germany Hungary Italy The Netherlands +4

  • Study of CVN424 for Reducing Motor Complications in Parkinson’s Disease Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • 1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
    Czechia France Italy Poland Spain

  • Study to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases

    Not recruiting

    3 1
    Investigated Diseases:
    • Interstitial lung disease
    • Rheumatic disorder
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria France Germany Italy The Netherlands Norway +1

  • Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Bulgaria France Germany Hungary Italy Poland +1

  • Study of SAR441566 compared to placebo for adults with moderate to severe Crohn’s disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Bulgaria Croatia Czechia France Germany Hungary +5

  • Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • TALADEGIB
    Austria Belgium France Germany Ireland Italy
Previous Page
1 … 23 24 25 26 27 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!